• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酰胺质子转移加权磁共振成像在预测世界卫生组织4级高级别胶质瘤中MGMTp甲基化状态、p53状态、Ki-67指数、异柠檬酸脱氢酶(IDH)状态及ATRX表达中的作用

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma.

作者信息

Durmo Faris, Lätt Jimmy, Rydelius Anna, Englund Elisabet, Salomonsson Tim, Liebig Patrick, Bengzon Johan, van Zijl Peter C M, Knutsson Linda, Sundgren Pia C

机构信息

Department of Clinical Sciences/Division of Radiology, Lund University, SE-221 00 Lund, Sweden.

Department of Medical Imaging and Physiology, Skåne University Hospital, SE-221 85 Lund, Sweden.

出版信息

Tomography. 2025 May 31;11(6):64. doi: 10.3390/tomography11060064.

DOI:10.3390/tomography11060064
PMID:40560010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12196788/
Abstract

To assess amide proton transfer weighted (APTw) MR imaging capabilities in differentiating high-grade glial tumors across alpha-thalassemia/mental retardation X-linked (ATRX) expression, tumor-suppressor protein p53 expression (p53), O6-methylguanine-DNA methyltransferase promoter (MGMTp) methylation, isocitrate dehydrogenase (IDH) status, and proliferation marker Ki-67 (Ki-67 index) as a preoperative diagnostic aid. A total of 42 high-grade glioma WHO grade 4 (HGG) patients were evaluated prospectively (30 males and 12 females). All patients were examined using conventional MRI, including the following: T1w-MPRAGE pre- and post-contrast administration, conventional T2w and 3D FLAIR, and APTw imaging with a 3T MR scanner. Receiver operating characteristic (ROC) curves were calculated for the APTw% mean, median, and max signal for the different molecular biomarkers. A logistic regression model was constructed for combined mean and median APTw% signals for p53 expression. The whole-tumor max APTw% signal could significantly differentiate MGMTp from non-MGMTp HGG, = 0.035. A cutoff of 4.28% max APTw% signal yielded AUC (area under the curve) = 0.702, with 70.6% sensitivity and 66.7% specificity. The mean/median APTw% signals differed significantly in p53 normal versus p53-overexpressed HGG s: 1.81%/1.83% vs. 1.15%/1.18%, = 0.002/0.006, respectively. Cutoffs of 1.25%/1.33% for the mean/median APTw% signals yielded AUCs of 0.786/0.757, sensitivities of 76.9%/76.9%, and specificities of 50%/66.2%, = 0.002/0.006, respectively. A logistic regression model with a combined mean and median APTw% signal for p53 status yielded an AUC = 0.788 and 76.9% sensitivity and 66.2% specificity. ATRX-, IDH- wild type (wt) vs. mutation (mut), and the level of Ki-67 did not differ significantly, but trends were found: IDH-wt and low Ki-67 showed higher mean/median/max APTw% signals vs. IDH-mut and high Ki-67, respectively. ATRX-wt vs. mutation showed higher mean and median APTw% signals but lower max APTw% signal. : APTw imaging can potentially be a useful marker for the stratification of p53 expression and MGMT status in high-grade glioma in the preoperative setting and potentially aid surgical decision-making.

摘要

评估酰胺质子转移加权(APTw)磁共振成像(MRI)在区分不同α-地中海贫血/智力发育迟缓X连锁(ATRX)表达、肿瘤抑制蛋白p53表达(p53)、O6-甲基鸟嘌呤-DNA甲基转移酶启动子(MGMTp)甲基化、异柠檬酸脱氢酶(IDH)状态以及增殖标志物Ki-67(Ki-67指数)的高级别胶质瘤方面的能力,作为术前诊断辅助手段。前瞻性评估了总共42例世界卫生组织4级高级别胶质瘤(HGG)患者(30例男性和12例女性)。所有患者均使用传统MRI进行检查,包括以下内容:T1w-MPRAGE对比剂注射前后、传统T2w和3D FLAIR,以及使用3T MR扫描仪进行APTw成像。针对不同分子生物标志物的APTw%均值、中位数和最大信号计算了受试者操作特征(ROC)曲线。构建了一个逻辑回归模型,用于p53表达的APTw%均值和中位数信号的组合。全肿瘤最大APTw%信号能够显著区分MGMTp甲基化与非MGMTp甲基化的HGG,P = 0.035。最大APTw%信号截断值为4.28%时,曲线下面积(AUC)= 0.702,敏感性为70.6%,特异性为66.7%。p53正常与p53过表达的HGG中,APTw%均值/中位数信号存在显著差异:分别为1.81%/1.83%与1.15%/1.18%,P分别为0.002/0.006。APTw%均值/中位数信号截断值为1.25%/1.33%时,AUC分别为0.786/0.757,敏感性为76.9%/76.9%,特异性为50%/66.2%,P分别为0.002/0.006。一个用于p53状态的APTw%均值和中位数信号组合的逻辑回归模型,AUC = 0.788,敏感性为76.9%,特异性为66.2%。ATRX、IDH野生型(wt)与突变型(mut)以及Ki-67水平无显著差异,但发现了一些趋势:IDH-wt和低Ki-67分别显示出比IDH-mut和高Ki-67更高的APTw%均值/中位数/最大信号。ATRX-wt与突变型相比,显示出更高的APTw%均值和中位数信号,但最大APTw%信号更低。结论:APTw成像可能是术前高级别胶质瘤中p53表达和MGMT状态分层的有用标志物,并可能有助于手术决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/e67f0129f28f/tomography-11-00064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/73d364157fa8/tomography-11-00064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/92673f84ea1f/tomography-11-00064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/439cb90554f0/tomography-11-00064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/e67f0129f28f/tomography-11-00064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/73d364157fa8/tomography-11-00064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/92673f84ea1f/tomography-11-00064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/439cb90554f0/tomography-11-00064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c6/12196788/e67f0129f28f/tomography-11-00064-g004.jpg

相似文献

1
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma.酰胺质子转移加权磁共振成像在预测世界卫生组织4级高级别胶质瘤中MGMTp甲基化状态、p53状态、Ki-67指数、异柠檬酸脱氢酶(IDH)状态及ATRX表达中的作用
Tomography. 2025 May 31;11(6):64. doi: 10.3390/tomography11060064.
2
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.使用 7.0T 弛豫补偿多池 CEST MRI 评估胶质瘤患者 IDH 突变和 MGMT 甲基化状态的可预测性。
Neuro Oncol. 2018 Nov 12;20(12):1661-1671. doi: 10.1093/neuonc/noy073.
3
Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri-Necrotic Regions on SWI Differentiates IDH Wild-Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma.磁敏感加权成像(SWI)上坏死及坏死周边区域存在瘤内破碎血栓形成的微血管,可将异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤与IDH突变型4级星形细胞瘤区分开来。
J Magn Reson Imaging. 2025 Jul;62(1):258-270. doi: 10.1002/jmri.29695. Epub 2025 Jan 9.
4
Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.采用酰胺质子转移加权 MRI 指标区分胶质母细胞瘤患者的 MGMT 启动子甲基化状态。
Eur Radiol. 2018 May;28(5):2115-2123. doi: 10.1007/s00330-017-5182-4. Epub 2017 Dec 12.
5
Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.多池化学交换饱和转移 MRI 在胶质瘤分级、分子亚型和评估肿瘤增殖中的应用。
J Neurooncol. 2024 Sep;169(2):287-297. doi: 10.1007/s11060-024-04729-9. Epub 2024 Jun 14.
6
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
7
Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.基于形态学 MRI、SWI、DWI 和 DSC-PWI 预测 IDH 突变型星形细胞瘤的 Ki-67 标记指数、 ATRX 突变和 MGMT 启动子甲基化状态。
Eur Radiol. 2023 Oct;33(10):7003-7014. doi: 10.1007/s00330-023-09695-w. Epub 2023 May 3.
8
Deep learning classification of MGMT status of glioblastomas using multiparametric MRI with a novel domain knowledge augmented mask fusion approach.使用具有新型领域知识增强掩码融合方法的多参数MRI对胶质母细胞瘤的MGMT状态进行深度学习分类。
Sci Rep. 2025 Jan 25;15(1):3273. doi: 10.1038/s41598-025-87803-0.
9
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study.MGMT 甲基化及其在不可切除 IDH 野生型胶质母细胞瘤中的预后意义:MGMT-GBM 研究。
Acta Neurochir (Wien). 2024 Oct 5;166(1):394. doi: 10.1007/s00701-024-06300-x.
10
Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.成人低级别胶质瘤患者 T2-FLAIR 不匹配征象与 IDH 突变状态的放射基因组关联:一项更新的系统评价和荟萃分析。
Eur Radiol. 2022 Aug;32(8):5339-5352. doi: 10.1007/s00330-022-08607-8. Epub 2022 Feb 15.

本文引用的文献

1
Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRI.使用灌注和酰胺质子转移加权磁共振成像鉴别胶质母细胞瘤与孤立性脑转移瘤
Front Neurosci. 2025 Feb 5;19:1533799. doi: 10.3389/fnins.2025.1533799. eCollection 2025.
2
The value of multimodal functional magnetic resonance imaging in differentiating p53abn from p53wt endometrial carcinoma.多模态功能磁共振成像在鉴别p53异常型与p53野生型子宫内膜癌中的价值
Acta Radiol. 2023 Nov;64(11):2948-2956. doi: 10.1177/02841851231198911. Epub 2023 Sep 3.
3
Tumor-neutrophil crosstalk promotes and glioblastoma progression.
肿瘤中性粒细胞相互作用促进胶质母细胞瘤进展。
Front Immunol. 2023 May 24;14:1183465. doi: 10.3389/fimmu.2023.1183465. eCollection 2023.
4
Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalities.用于预测弥漫性脑桥内在型胶质瘤基因组突变的多模态MRI影像组学模型,其中存在缺失的成像模态。
Front Med (Lausanne). 2023 Feb 23;10:1071447. doi: 10.3389/fmed.2023.1071447. eCollection 2023.
5
Evolution-driven crosstalk between glioblastoma and the tumor microenvironment.胶质母细胞瘤与肿瘤微环境之间由进化驱动的串扰
Cancer Biol Med. 2023 Mar 8;20(5):319-24. doi: 10.20892/j.issn.2095-3941.2022.0771.
6
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma.三维酰胺质子转移加权成像用于鉴别胶质母细胞瘤、异柠檬酸脱氢酶野生型和原发性中枢神经系统淋巴瘤
Cancers (Basel). 2023 Feb 2;15(3):952. doi: 10.3390/cancers15030952.
7
BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network.BRD8 通过表观遗传重编程 p53 网络维持神经胶质瘤。
Nature. 2023 Jan;613(7942):195-202. doi: 10.1038/s41586-022-05551-x. Epub 2022 Dec 21.
8
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.脑胶质瘤中肿瘤与免疫微环境的自然协同进化。
Cancer Discov. 2022 Dec 2;12(12):2820-2837. doi: 10.1158/2159-8290.CD-22-0196.
9
Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma.结合术前磁共振成像的影像组学和深度卷积神经网络特征以预测胶质母细胞瘤中临床相关的遗传生物标志物。
Neurooncol Adv. 2022 Apr 22;4(1):vdac060. doi: 10.1093/noajnl/vdac060. eCollection 2022 Jan-Dec.
10
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.3T 临床 APT 加权成像方法的回顾与共识建议:在脑肿瘤中的应用。
Magn Reson Med. 2022 Aug;88(2):546-574. doi: 10.1002/mrm.29241. Epub 2022 Apr 22.